Navigation Links
Dysfunctional chemokine receptor promotes candidiasis
Date:11/1/2013

Candida albicans is one of the leading causes of hospital-acquired infections in immune compromised patients. The risk of both developing candidiasis and the clinical outcome of infection is variable among patients, and the host-dependent factors that contribute to patient susceptibility to C. albicans infection are poorly understood. In this issue of the Journal of Clinical Investigation, Michail Lionakis and colleagues at the National Institute of Allergy and Infectious Diseases demonstrated that the chemokine receptor CX3CR1 is required for the interaction of C. albicans and macrophages in the kidney. Mice lacking this receptor were prone to C. albicans-induced kidney failure; however, these mice did not have increased fungal burden in other organs. Furthermore, the authors found that patients with a mutation in the gene encoding CX3CR1 were at higher risk of candidiasis. This study identifies an important role for the interaction of C. albicans and macrophages in disease progression and outcome.


'/>"/>

Contact: Corinne Williams
press_releases@the-jci.org
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related biology news :

1. Has modern science become dysfunctional?
2. Measuring progesterone receptor expression to improve hormone-receptor-positive cancer management
3. G protein-coupled receptor mediates the action of castor oil
4. BUSM study identifies receptors role in regulating obesity, type 2 diabetes
5. Cell receptor has proclivity for T helper 9 cells, airway inflammation
6. Steroid hormone receptor prefers working alone to shut off immune system genes
7. Jackson Laboratory researchers provide definitive proof for receptors role in synapse development
8. Dopamine-receptor gene variant linked to human longevity
9. How the tilt of a cell-surface receptor prevents cancer
10. Activation of cortical type 2 cannabinoid receptors ameliorates ischemic brain injury
11. Therapies for ALL and AML targeting MER receptor hold promise of more effect with less side-effect
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2018)... ... November 19, 2018 , ... SF Bay Cosmetic Body ... first and only non-invasive buttock lift procedure, with no injections necessary! Utilizing HIFEM® ... and firm the buttocks to provide a safe and completely non-invasive alternative to ...
(Date:11/16/2018)... WASHINGTON (PRWEB) , ... November 16, 2018 , ... ... It is called All Things Chemical™ and it will engage listeners in ... the law and business issues surrounding chemicals. B&C’s talented team of lawyers, scientists, ...
(Date:11/15/2018)... ... November 15, 2018 , ... Firmex today released new research ... surveyed over 480 investment bankers and M&A advisors worldwide to compile the third annual ... on the key findings in the report. , Highlights in the 2018-19 Report:, ...
Breaking Biology News(10 mins):
(Date:11/13/2018)... ... November 12, 2018 , ... AseptiScope(TM), Inc. announces ... large U.S. studies, published last week, confirm pose a significant health risk. ... (AJIC) conclude that stethoscopes are often improperly or rarely disinfected. In the AJIC ...
(Date:11/13/2018)... ... November 13, 2018 , ... , Park Systems, world ... China. With the increasingly growing demand for AFM technology in China, Park Systems has ... by opening an office in Beijing equipped with Park AFM. , The Grand Opening ...
(Date:11/9/2018)... ... November 08, 2018 , ... ... Valenzuela, PhD, co-Founder, Chief Executive Officer and President of Andes Biotechnologies, to its ... the world, Dr. Valenzuela brings to uBiome expertise on the genetic studies of ...
(Date:11/7/2018)... ... November 07, 2018 , ... Since September of ... increase awareness of the adult tissue stem cell counting problem in stem cell ... company is intensifying this effort with new educational publications and presentations at clinical ...
Breaking Biology Technology: